ISAR-REACT 4 – Bivalirudin Similar to Abciximab/Heparin in Reducing Ischemic Outcomes in NSTEMI and Has Significantly Less Bleeding

Article Information

DOI 
http://dx.doi.org/10.1177/155989771115008
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2011 MD Conference Express®

Author Information

  1. Rita Buckley
  1. Adnan Kastrati, MD
    1. Deutsches Herzzentrum, Technische Universitat, Munich, Germany
View Full Text

Article usage

AbstractFullPDF
Apr 2015500
May 2015100
Jul 20152021
Aug 2015700
Sep 2015700
Oct 2015132
Nov 2015100
Total4253

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
ISAR-REACT 4 – Bivalirudin Similar to Abciximab/Heparin in Reducing Ischemic Outcomes in NSTEMI and Has Significantly Less Bleeding
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Cardiology Clinical Trials
Interventional Techniques & Devices
Myocardial Infarction